Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts  Chiara Raggi, Pietro Invernizzi,

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Daniela Sia, Augusto Villanueva, Scott L. Friedman, Josep M. Llovet 
The GAPs between hepatocellular carcinoma and RAS
Volume 152, Issue 5, Pages (April 2017)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Molecular pathogenesis of follicular cell derived thyroid cancers
Jean-Charles Nault, Jessica Zucman-Rossi  Journal of Hepatology 
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Daniela Sia, Augusto Villanueva, Scott L. Friedman, Josep M. Llovet 
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
The origin of cancer stem cells
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
The place of downstaging for hepatocellular carcinoma
The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver – A systematic review  Otto Strauss, P. Rod.
The progenitor cell dilemma: Cellular and functional heterogeneity in assistance or escalation of liver injury  Veronika Lukacs-Kornek, Frank Lammert 
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Volume 65, Issue 4, Pages (October 2016)
Volume 68, Issue 1, Pages (January 2018)
Hepatitis C core protein – The “core” of immune deception?
Jean-Charles Nault, Peter R. Galle, Jens U. Marquardt 
Volume 148, Issue 4, Pages (April 2015)
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Targets for immunotherapy of liver cancer
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Why men are at higher risk for hepatocellular carcinoma?
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Volume 43, Issue 4, Pages (October 2005)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Pierre Nahon, Jessica Zucman-Rossi  Journal of Hepatology 
Volume 62, Issue 2, Pages (February 2015)
Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn 
S. Tamir Rashid, Graeme J.M. Alexander  Journal of Hepatology 
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Notch Signaling in Hepatocellular Carcinoma: Guilty in Association!
Volume 61, Issue 1, Pages S79-S90 (November 2014)
Chetana Lim, Chady Salloum, Daniel Azoulay
Evolution of liver transplantation for hepatocellular carcinoma
The potential of induced pluripotent stem cell derived hepatocytes
Kornelius Schulze, Jean-Charles Nault, Augusto Villanueva 
Combined locoregional-immunotherapy for liver cancer
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Volume 63, Issue 1, Pages (July 2015)
The dynamic biliary epithelia: Molecules, pathways, and disease
Volume 66, Issue 3, Pages (March 2017)
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Volume 65, Issue 4, Pages (October 2016)
HCV animal models and liver disease
New trials and results in systemic treatment of HCC
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Volume 60, Issue 6, Pages (June 2014)
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris 
A 360-degree overview of paediatric NAFLD: Recent insights
Volume 58, Issue 2, Pages (February 2013)
Genetics of hepatocellular carcinoma: The next generation
Nathalie Ganne-Carrié, Pierre Nahon  Journal of Hepatology 
Volume 60, Issue 6, Pages (June 2014)
Presentation transcript:

Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts  Chiara Raggi, Pietro Invernizzi, Jesper B. Andersen  Journal of Hepatology  Volume 62, Issue 1, Pages 198-207 (January 2015) DOI: 10.1016/j.jhep.2014.09.007 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Multiple cells-of-origin in cholangiocarcinoma. Cholangiocarcinoma (CCA) may originate by deregulation of oncogenic programs in a range of liver lineages. Alternatively tumours dedifferentiate and acquire progenitor features during carcinogenesis (dedifferentiation theory, red arrow). CCA heterogeneity may derive from different cells-of-origin as well as from diverse genetic mutations responsible for the dynamic differentiation/de-differentiation processes among different tumour subtypes. (HCC, hepatocellular carcinoma, CLC, cholangiocellular carcinoma; CHC, mixed CCA-HCC tumour types; CLHCC, CCA-like HCC; S-HCC, scirrhous HCC, a variant of HCC with abundant fibrous stroma). Journal of Hepatology 2015 62, 198-207DOI: (10.1016/j.jhep.2014.09.007) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Cholangiocarcinoma-associated microenvironment. Tumour microenvironment related to cholangiocarcinoma includes cancer-associated fibroblasts (CAFs) and macrophage component. Crosstalk among different microenvironmental components is involved in the activation of CCA oncogenic signalling. Journal of Hepatology 2015 62, 198-207DOI: (10.1016/j.jhep.2014.09.007) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2015 62, 198-207DOI: (10. 1016/j. jhep. 2014. 09 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions